Showing results (1421-1430 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|April 21, 2012
miRNAs in breast cancer: ready for real time?Jonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Pharmacogenomics|April 21, 2012
The importance of nonpharmacogenetic factors in endocrine therapyColin McCowan, Alastair M Thompson
Pharmacogenomics|May 17, 2016
Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patientsElisabeth J Kap, Odilia Popanda, Jenny Chang-Claude
Pharmacogenomics|May 12, 2016
Cost-effectiveness analysis of personalized antiplatelet therapy in patients with acute coronary syndromeMinghuan Jiang, Joyce Hs You
Pharmacogenomics|June 14, 2016
Pharmacogenetic considerations in the treatment of Alzheimer's diseaseRamón Cacabelos, Clara Torrellas, Oscar Teijido, et al.
Pharmacogenomics|July 14, 2016
Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patientsZhi Peng Wen, Shuang Shi Fan, Can Du, et al.
Pharmacogenomics|July 27, 2017
Anaplastic lymphoma kinase rearrangements in non-small-cell lung cancer: novel applications in diagnostics and treatmentRodney E Shackelford, Junaid M Ansari, Eric X Wei, et al.
Pharmacogenomics|July 27, 2017
The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifenAnabel B Sanchez-Spitman, Dirk-Jan Ar Moes, Hans Gelderblom, et al.
Pharmacogenomics|July 27, 2017
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicityMarta Pellicer, Xandra García-González, María I García, et al.
Pharmacogenomics|March 30, 2016
Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's diseaseVivian Altmann, Artur F Schumacher-Schuh, Mariana Rieck, et al.
Pageof 274